Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address Please contact the publisher to request reinstatement.
July 8, 1916

Inhibitory Properties of Magnesium Sulphate and Their Therapeutic Application in Tetanus

JAMA. 1916;LXVII(2):143. doi:10.1001/jama.1916.02590020059026

This article is only available in the PDF format. Download the PDF to view the article, as well as its associated figures and tables.


To the Editor:  —I have discovered an important omission in my article on this subject (The Journal, March 25, 1916, p. 931), an omission which may have practical consequences. On page 934, second column, the first paragraph of the summary reads: "In each and every case of tetanus, 1.2 c.c. of a 25 per cent, solution of magnesium sulphate should be given by subcutaneous injection," etc. It should read: "1.2 c.c. of a 25 per cent. solution of magnesium sulphate perkilogram body weight."

First Page Preview View Large
First page PDF preview
First page PDF preview